Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer
Abstract Background Ovarian cancer is the second most common gynaecologic malignancy and the most common cause of death from gynaecologic cancer, especially due to diagnosis at an advanced stage, when a cure is rare. As ovarian tumour grows, cancer cells are exposed to regions of hypoxia. Hypoxia is...
Main Authors: | Sofia C. Nunes, Filipa Lopes-Coelho, Sofia Gouveia-Fernandes, Cristiano Ramos, Sofia A. Pereira, Jacinta Serpa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | BMC Evolutionary Biology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12862-018-1214-1 |
Similar Items
-
Cysteine Boosts Fitness Under Hypoxia-Mimicked Conditions in Ovarian Cancer by Metabolic Reprogramming
by: Sofia C. Nunes, et al.
Published: (2021-08-01) -
Cysteine as a Carbon Source, a Hot Spot in Cancer Cells Survival
by: Jacinta Serpa, et al.
Published: (2020-06-01) -
Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity
by: Sofia C. Nunes, et al.
Published: (2018-06-01) -
Hypoxia-inducible factor induces cysteine dioxygenase and promotes cysteine homeostasis in Caenorhabditis elegans
by: Kurt Warnhoff, et al.
Published: (2024-02-01) -
Cysteine Aminotransferase (CAT): A Pivotal Sponsor in Metabolic Remodeling and an Ally of 3-Mercaptopyruvate Sulfurtransferase (MST) in Cancer
by: Ana Hipólito, et al.
Published: (2020-09-01)